Internal Medicine, Nephrology · Des Moines, IA
NPI
1518969104
Since 2005
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
411 Laurel St, Suite 2350
Des Moines, IA, 50314
Phone (515) 280-4700
Groups this clinician bills Medicare through
Medicare paid, 2024
$136K
1,374 services
Medicare patients, 2024
509
Average age 75
Drug cost, 2024
$30K
867 prescriptions
Company payments, 2025
$1,535
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Prem K Chandran was code 99232 (hospital e&m - subsequent), 329 times for 163 patients. In total Prem K Chandran billed 1,374 services in 17 codes, and Medicare paid $136K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-01-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 329 | 163 | $57.75 | $19K |
| 99214 Office E&M - Established | Office | 328 | 218 | $90.92 | $30K |
| 99233 Hospital E&M - Subsequent | Facility | 192 | 71 | $87.18 | $17K |
| 90962 ESRD Related Services (not dialysis) | Office | 129 | 29 | $148.72 | $19K |
| 90961 ESRD Related Services (not dialysis) | Office | 91 | 15 | $216.03 | $20K |
| 99222 Hospital E&M - Initial | Facility | 61 | 59 | $95.57 | $5,830 |
| 90935 Hemodialysis | Facility | 51 | 27 | $52.32 | $2,668 |
| 99204 Office E&M - New | Office | 48 | 48 | $119.10 | $5,717 |
| 99231 Hospital E&M - Subsequent | Facility | 30 | 26 | $36.23 | $1,087 |
| 99223 Hospital E&M - Initial | Facility | 24 | 22 | $127.32 | $3,056 |
| 99215 Office E&M - Established | Office | 22 | 13 | $132.88 | $2,923 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 12 | 12 | $12.18 | $146 |
By year: 2022 $144K for 1,550 services; 2023 $148K for 1,512 services; 2024 $136K for 1,374 services.
Medicare prescription drug claims, 2024
In 2024, the drug Prem K Chandran prescribed most often to Medicare patients was Doxazosin Mesylate, with 130 prescriptions and refills. In total Prem K Chandran wrote 867 Medicare prescriptions that cost $30K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Doxazosin Mesylate Generic | 130 | 298 | 35 | $2,373 |
| Furosemide Generic | 66 | 148 | 26 | $248 |
| Amlodipine Besylate Generic | 54 | 124 | 15 | $325 |
| Losartan Potassium Generic | 50 | 126 | 14 | $473 |
| Potassium Chloride Generic | 47 | 80 | 13 | $2,749 |
| Bumetanide Generic | 38 | 67 | 11 | $567 |
| Spironolactone Generic | 32 | 60 | Under 11 | $55.41 |
| Allopurinol Generic | 32 | 74 | Under 11 | $224 |
| Metolazone Generic | 29 | 63 | 12 | $315 |
| Carvedilol Generic | 19 | 31 | Under 11 | $241 |
| Calcium Acetate Generic | 18 | 18 | Under 11 | $570 |
| Metoprolol Succinate Generic | 18 | 42 | Under 11 | $440 |
| Atorvastatin Calcium Generic | 17 | 31 | Under 11 | $117 |
| Hydrochlorothiazide Generic | 17 | 25 | Under 11 | $19.24 |
| Tamsulosin Hcl Generic | 17 | 45 | Under 11 | $343 |
Brand drugs: - claims; generic drugs: 802 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Prem K Chandran $1,535 ($1,535 in general payments such as food, travel and fees) from 13 companies. The largest payer was Travere Therapeutics, Inc. with $866.
| Company | Payments | Amount |
|---|---|---|
| Travere Therapeutics, Inc. TVTX | 8 | $866 |
| Novartis Pharmaceuticals Corporation NVS | 13 | $295 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 3 | $66.58 |
| Amgen Inc. AMGN | 3 | $59.45 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $53.72 |
| Calliditas Therapeutics US Inc. | 1 | $38.42 |
| Veloxis Pharmaceuticals, Inc. | 1 | $37.53 |
| Genentech USA, Inc. ROG.SW | 1 | $29.78 |
| Scpharmaceuticals Inc. SCPH | 1 | $22.51 |
| Ardelyx, Inc. ARDX | 1 | $17.35 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.